At a glance
- Inaugural event: May 21-24, 2026 at Resorts World Las Vegas
- Athletes publicly disclose BPC-157, CJC-1295, Ipamorelin, and TB-500 use
- $1.2 billion valuation via SPAC merger, targeting NASDAQ ticker ENHA
- Magnussen swam 50m freestyle in 20.89s, beating the 2009 world record
- Live Enhanced wellness platform is the revenue engine, not the games
The pitch is simple: stop pretending
For decades, elite sport has operated on a polite fiction. Athletes dope. Governing bodies test. Catches happen just often enough to keep the system looking functional. Meanwhile, the real pharmacology stays three steps ahead of the lab.
The Enhanced Games wants to tear that curtain down.
Founded in 2023 by Australian lawyer-turned-entrepreneur Dr. Aron D'Souza, the Enhanced Games is a planned multi-sport competition where performance-enhancing substances are not just tolerated but openly disclosed. No drug tests. No bans. Athletes tell the medical staff exactly what they are taking, receive cardiac screening and blood panels, and then compete.
The inaugural event is set for May 21 to 24, 2026 at Resorts World Las Vegas. Three sports. Roughly 50 athletes. A purpose-built venue with a 4-lane 50-meter pool, a 6-lane sprint track, and a weightlifting stage. Prize money that makes most Olympic sports look like hobby leagues.
And a $1.2 billion valuation.
The money behind the curtain
The investor list reads like a who's-who of Silicon Valley contrarianism. Peter Thiel (PayPal, Palantir) led the seed round alongside Christian Angermayer (Apeiron Investment Group) and Balaji Srinivasan (former Coinbase CTO). Later rounds brought in the Winklevoss twins, Donald Trump Jr. through 1789 Capital, and Prince Khaled bin Alwaleed Al Saud.
In November 2025, Enhanced Ltd announced a SPAC merger with A Paradise Acquisition Corp (NASDAQ: APAD) at a $1.2 billion enterprise value. The combined company will list on NASDAQ under the ticker ENHA, and the deal is expected to close in the first half of 2026. If it does, Enhanced becomes the first publicly traded company built around open PED use in sport.
The money is not just about the games. Enhanced Ltd operates two principal business lines: the sporting events themselves and Live Enhanced, a direct-to-consumer wellness platform selling clinician-guided hormone optimization, peptide protocols, and supplement stacks. The games are the attention engine. The wellness platform is the revenue engine.
What athletes are actually taking
This is where it gets directly relevant to anyone reading this site.
James Magnussen, the Australian Olympic silver medalist who came out of retirement specifically for the Enhanced Games, has publicly disclosed his full PED stack:
- Testosterone at supraphysiological doses
- BPC-157 (Body Protection Compound-157)
- CJC-1295 (modified GHRH analog)
- Ipamorelin (selective GHRP)
- Thymosin Beta-4 / TB-500
If you are a peptide researcher, you will recognize that list immediately. BPC-157 + TB-500 is the Wolverine Stack. CJC-1295 + Ipamorelin is the FIT Stack. Magnussen is essentially running two of the most popular pre-mixed peptide protocols on the market, layered on top of a testosterone base.
The result: Magnussen gained roughly 20 kg of muscle and swam a 50-meter freestyle time of 20.89 seconds in an early showcase event. That is faster than Cesar Cielo's 2009 world record of 20.91. Greek-Bulgarian swimmer Kristian Gkolomeev matched that 20.89 time at the February 2025 showcase in Greensboro and claimed the $1 million world record bonus.
The athlete roster
38 athletes were confirmed as of February 2026, with a target of 50 for the inaugural event. The roster splits across three sports:
Swimming has attracted the biggest names. Alongside Magnussen and Gkolomeev, the lineup includes Hunter Armstrong (two-time Olympic gold, USA), Ben Proud (Olympic gold, UK), Shane Ryan (Ireland, Olympian), Andriy Govorov (Ukraine, 50m butterfly world record holder), and Megan Romano (USA, multiple relay golds as the first female athlete to sign).
Armstrong's situation is particularly interesting. He joined on March 3, 2026 as a self-declared "Non-Enhanced Athlete", meaning he will compete clean against enhanced competitors. His motivation is financial: his primary sponsor dropped him, and the Enhanced Games pay a salary plus prize money. He believes he can remain eligible for future Olympic teams as long as he stays in the WADA testing pool.
Track and field features Marvin Bracy-Williams (USA, former world silver medalist currently serving a 45-month USADA ban), Clarence Munyai (South Africa), and several other sprinters.
Weightlifting rounds out the lineup with snatch and clean-and-jerk events.
The sports and the money
Three sports. Eight swimming events (50m and 100m freestyle, 50m and 100m butterfly). Sprint events (100m, 110m hurdles for XY division, 100m hurdles for XX). Olympic weightlifting (snatch, clean and jerk).
Prize purses are significant:
- $500,000 per event ($250K to the winner, $250K split among remaining competitors)
- $250,000 bonus for breaking an official world record
- $1,000,000 bonus for world records in the 50m freestyle or 100m sprint
For context, Olympic athletes receive zero prize money from the IOC. National federations sometimes offer bonuses (USA pays $37,500 for gold), but the Enhanced Games purse dwarfs traditional sport compensation for all but the very top tier.
Gender divisions use XX and XY chromosome categories rather than male/female designations. This is a choice that has drawn criticism from the scientific community, since chromosome-based sex verification was abandoned in mainstream sport by the late 1990s.
The safety question
The most serious objection to the Enhanced Games is the health risk.
Enhanced claims athletes must pass medical screening, disclose all substances, and submit to cardiac profiling and regular bloodwork. An Independent Medical Commission of cardiologists, endocrinologists, and pharmacologists oversees protocols. Only "FDA-approved substances" are supposed to be allowed (partly for insurance reasons), and outright dangerous substances or Class A drugs are prohibited.
The problem: several compounds Magnussen disclosed using, including BPC-157, CJC-1295, Ipamorelin, and TB-500, are not FDA-approved. They are research peptides. This contradiction between the official "FDA-approved only" policy and the actual disclosed stacks has not been convincingly resolved.
Critics are not shy about the risks. Travis Tygart (USADA CEO) called it "a dangerous clown show." Witold Banka (WADA president) called it "ridiculous" and "very dangerous." Multiple peer-reviewed papers in journals like Frontiers and the British Journal of Sports Medicine have analyzed the medical and ethical concerns.
The counterargument from Enhanced supporters: many accepted sports (boxing, MMA, motorsport, American football) already involve enormous bodily risk. The prohibition model pushes doping underground, where athletes use unknown substances without medical supervision. Open use with medical oversight, the argument goes, is actually safer than the status quo.
It is a debate without a clean answer.
The business model: games first, peptides second
Here is the part most commentary misses. The Enhanced Games are not a standalone sporting event. They are a customer acquisition funnel for Live Enhanced, the company's direct-to-consumer wellness platform.
Live Enhanced currently sells clinician-guided Sermorelin (an FDA-approved GHRH analog) and plans to add Tesamorelin, Glutathione, and Oxytocin. They also offer hormone replacement therapy for men and women, proprietary supplement lines (STRONGER+ for performance, LONGER+ for longevity), and coaching protocols.
The SPAC filing makes this explicit. Enhanced Ltd's two principal revenue streams are (1) live sporting events and (2) consumer wellness products. The games generate massive media coverage; the wellness platform monetizes the audience.
For the peptide market specifically, the Enhanced Games represent something unprecedented: a mainstream, billion-dollar media event where peptide compounds are discussed openly on camera by elite athletes. BPC-157, CJC-1295, and Ipamorelin have never had this kind of visibility. Whether that visibility ultimately helps or hurts the research peptide space is an open question.
The legal battlefield
Enhanced filed an $800 million antitrust lawsuit against World Aquatics, WADA, and USA Swimming, alleging they illegally coordinated to prevent athletes from competing. A federal judge in New York dismissed the case, ruling Enhanced failed to show World Aquatics holds monopoly power. Enhanced was given 30 days to refile but chose not to appeal.
The legal question for athletes is murkier. Hunter Armstrong believes he can compete at the Enhanced Games and remain Olympic-eligible as long as he stays clean and in WADA's testing pool. Whether that interpretation holds up under the various federations' rules remains untested. Any currently active Olympic athlete who competes could face sanctions, although the legal basis for punishing someone who doesn't actually violate any anti-doping rule by competing alongside enhanced athletes is unclear.
The leadership shuffle
A notable development: D'Souza stepped down as CEO in November 2025 and was replaced by Maximilian Martin, an investment banker and co-founder of Bitfield (a bitcoin mining company acquired by Northern Data for approximately EUR 400 million). D'Souza remains a shareholder but is no longer running day-to-day operations.
Whether this signals instability or a natural transition from founder-led startup to operator-led company is debatable. The timing, right before the SPAC announcement, suggests it was planned as part of the public-company transition.
What this means for peptide research
The Enhanced Games put peptide compounds in front of a global audience for the first time. When James Magnussen stands on a podium and tells cameras he is running BPC-157, CJC-1295, Ipamorelin, and TB-500, that is unprecedented mainstream exposure for compounds that have historically existed in a niche research community.
The potential upside: normalized conversation around peptide research, increased public understanding of what these compounds do and how they work, and a possible push toward more clinical research and eventual regulatory pathways.
The potential downside: association with "steroid Olympics" framing could paint peptides with a broader PED brush, regulatory backlash from increased visibility, and misinformation as mainstream media inevitably oversimplifies the pharmacology.
Regardless of where you land on the ethics, the Enhanced Games are now a $1.2 billion reality heading for NASDAQ. They will happen in Las Vegas in May 2026. And the compounds at the center of the conversation are the same ones you will find throughout this site.
Key dates
- May 21-24, 2026: Inaugural Enhanced Games, Resorts World Las Vegas
- First half of 2026: Expected close of SPAC merger (NASDAQ: ENHA)
- 38 athletes confirmed as of February 2026, targeting 50
Compounds referenced by Enhanced Games athletes
| Compound | Type | FDA Status | Our guide |
|---|---|---|---|
| Testosterone | Hormone | Approved (Rx) | N/A |
| BPC-157 | Peptide | Not approved | BPC-157 guide |
| TB-500 | Peptide | Not approved | TB-500 guide |
| CJC-1295 | Peptide (GHRH) | Not approved | CJC-1295 guide |
| Ipamorelin | Peptide (GHRP) | Not approved | Ipamorelin guide |
| Sermorelin | Peptide (GHRH) | Approved (Rx) | Sermorelin guide |
Pre-mixed stacks used by Enhanced Games athletes
Magnussen's disclosed protocol maps directly to commercially available pre-mixed stacks:
- Wolverine Stack (BPC-157 + TB-500): The recovery foundation of his protocol. Targets tissue repair, anti-inflammation, and angiogenesis.
- FIT Stack (CJC-1295 + Ipamorelin): The growth hormone optimization layer. Synergistic GHRH + GHRP pairing for natural GH release.
Both stacks are available from our partner Ascension Peptides with 50% off using code ENHANCED.
This article is for educational and informational purposes only. The Enhanced Games and all referenced compounds involve complex medical, legal, and ethical considerations. We do not endorse the use of any substance for purposes other than legitimate research. Always consult a qualified healthcare professional.